Tenaya Therapeutics/$TNYA
1D1W1MYTD1Y5YMAX
Capital at risk
About Tenaya Therapeutics
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
- Ticker
- $TNYA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 70
- Headquarters
- South San Francisco, United States
- Website
- www.tenayatherapeutics.com
TNYA Metrics
BasicAdvanced
$151M
-
-$0.53
2.79
-
Price and volume
Market cap
$151M
Beta
2.79
52-week high
$2.35
52-week low
$0.53
Average daily volume
1.9M
Financial strength
Current ratio
4.522
Quick ratio
4.125
Long term debt to equity
0.015
Total debt to equity
0.057
Profitability
EBITDA (TTM)
-75.524
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-7,723.97%
Operating margin (TTM)
-6,192.96%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-47.91%
Return on equity (TTM)
-121.86%
Valuation
Price to revenue (TTM)
97.364
Price to book
2.17
Price to tangible book (TTM)
2.17
Price to free cash flow (TTM)
-2.471
Free cash flow yield (TTM)
-40.46%
Free cash flow per share (TTM)
-0.272
Growth
Earnings per share change (TTM)
-40.37%
3-year earnings per share growth (CAGR)
-36.92%
What the Analysts think about TNYA
Analyst ratings (Buy, Hold, Sell) for Tenaya Therapeutics stock.
Analyst projections of the future price of Tenaya Therapeutics stock.
TNYA Financial Performance
Revenues and expenses
TNYA Earnings Performance
Company profitability
Upcoming events
No upcoming events
TNYA News
AllArticlesVideos
Funds containing TNYA
AllUSDGBP
Fund name | Fund size | $TNYA weighting |
|---|---|---|
iShares Nasdaq US Biotechnology$BTEC | $1.2B | 0.01% |
iShares Nasdaq US Biotechnology£BTEK | £865M | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.